Blog
RSS FeedPosted by Michael Wonder on 13 Jan 2017
Interpretation of surrogate endpoints in the era of the 21st Century Cures Act
14 January 2017 - Surrogate endpoints are commonly used in clinical trials to get quicker results, but Kevin Knopf and ...
Posted by Michael Wonder on 12 Jan 2017
What Trump gets wrong about drug companies
12 January 2017 - President-elect Donald Trump was hardly timid in declaring Wednesday that drug companies are “getting away with ...
Posted by Michael Wonder on 12 Jan 2017
Biopharma needs to stop getting blindsided by Donald Trump
11 January 2017 - The day after Donald Trump won the US presidential election, pharma and biotech investors seemed to ...
Posted by Michael Wonder on 11 Jan 2017
National Cancer Institute and drug companies aim to speed up clinical trials
11 January 2017 - The National Cancer Institute launched an effort Wednesday to speed up clinical trials by getting researchers ...
Posted by Michael Wonder on 08 Jan 2017
Don’t thank big government for medical breakthroughs
5 January 2017 - New cures come from private research, not cash dumped into the National Institutes of Health. ...
Posted by Michael Wonder on 05 Jan 2017
New “21st Century Cures” legislation: speed and ease versus science
5 January 2017 - The 21st Century Cures Act was signed into law in December 2016. Praised by its advocates as ...
Posted by Michael Wonder on 04 Jan 2017
The changing face of clinical trials: the large pharmaceutical company perspective
4 January 2017 - Large pharmaceutical companies conduct clinical trials to evaluate efficacy and identify safety issues for candidate drugs as ...
Posted by Michael Wonder on 30 Dec 2016
FDA completes guidance on the development of biosimilars
29 December 2016 - Drug makers received guidance from the FDA on 28 December on the development of biosimilar medicines. ...
Posted by Michael Wonder on 27 Dec 2016
Negative control outcomes: a tool to detect bias in randomised trials
27 December 2016 - Investigators have several design, measurement, and analytic tools to detect and reduce bias in epidemiological studies. One ...
Posted by Michael Wonder on 22 Dec 2016
FDA officials call for including adolescents in adult oncology trials
20 December 2016 - A team of officials at the US FDA are calling for a "culture shift" by drug ...
Posted by Michael Wonder on 20 Dec 2016
Harnessing the U.S. taxpayer to fight cancer and make profits
19 December 2016 - Enthusiasm for cancer immunotherapy is soaring, and so is Arie Belldegrun’s fortune. ...
Posted by Michael Wonder on 15 Dec 2016
A new type of molecular medicine may be needed to halt cancers
16 December 2016 - Doctors must look to proteins rather than genes to tackle tumours. ...
Posted by Michael Wonder on 15 Dec 2016
Transforming evidence generation to support health and health care decisions
14 December 2016 - Making better choices about health and health care requires the best possible evidence. Unfortunately, many of the ...
Posted by Michael Wonder on 14 Dec 2016
The 21st Century Cures Act — a view from the NIH
14 December 2016 - The Cures Act, formally known as H.R. 34 or the 21st Century Cures Act, passed overwhelmingly in ...
Posted by Michael Wonder on 14 Dec 2016
Obama signs $6.3 billion law for cancer research, drug treatment
14 December 2016 - President Barack Obama has signed into law legislation that makes new investments in cancer research and battling ...